In 2017, a group of bioengineers at the University of Victoria designed and developed a prototype smart dressing with breakthrough technology in wound management. After two years of refinement, the team won the Michael Smith Foundation’s Innovation to Commercialization Award to further advance its technology and progress it towards market trials.
With the revolutionary technology gaining momentum, 4M BioTech Ltd. was launched as a spin-off company* to support the project’s ambitions. Today, 4M BioTech Ltd. strives to save lives through bridging collective knowledge and establishing solutions at the interface of cellular biology, biomaterials, mechanical engineering, and artificial intelligence. With a strong innovation culture, the company’s multidisciplinary team of acclaimed experts bring their passion, knowledge, and expertise to utilize cross-disciplinary synergies and find tech-based solutions to unaddressed world health crises.
*4M BioTech Ltd. Is licensed by the University of Victoria, which reserves the exclusive rights to the Intellectual Property resulting from the GelDerm wound dressing.
At 4M Biotech, we believe creative problem solving is most effective when multiple perspectives and techniques are taken into consideration. Our diverse team of renowned experts utilize cross-disciplinary collaboration to navigate the complex journey of biotechnology development.